A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Heptabarbital
Glycyrrhizic acid
Lenvatinib may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.
Heptabarbital
Dihydroergocristine
Lenvatinib may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level.
Heptabarbital
Pilsicainide
Lenvatinib may decrease the excretion rate of Pilsicainide which could result in a higher serum level.
Heptabarbital
Benzbromarone
Lenvatinib may decrease the excretion rate of Benzbromarone which could result in a higher serum level.
Heptabarbital
Indocyanine green acid form
Lenvatinib may decrease the excretion rate of Indocyanine green acid form which could result in a higher serum level.
Heptabarbital
Methoxy polyethylene glycol-epoetin beta
The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Lenvatinib.
Heptabarbital
Peginesatide
The risk or severity of Thrombosis can be increased when Peginesatide is combined with Lenvatinib.
Heptabarbital
Ivabradine
Ivabradine may increase the QTc-prolonging activities of Lenvatinib.
Butobarbital
Oliceridine
The risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when Umeclidinium is combined with Oliceridine.
Butobarbital
Tucatinib
Umeclidinium may decrease the excretion rate of Tucatinib which could result in a higher serum level.
Butobarbital
Givosiran
The serum concentration of Umeclidinium can be increased when it is combined with Givosiran.
Butobarbital
Lasmiditan
The serum concentration of Umeclidinium can be increased when it is combined with Lasmiditan.
Butobarbital
Erdafitinib
The serum concentration of Umeclidinium can be increased when it is combined with Erdafitinib.
Butobarbital
Solriamfetol
The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Umeclidinium.
Butobarbital
Macimorelin
The therapeutic efficacy of Macimorelin can be decreased when used in combination with Umeclidinium.
Butobarbital
Belantamab mafodotin
The serum concentration of Belantamab mafodotin can be increased when it is combined with Umeclidinium.
Butobarbital
Prednisolone phosphate
The serum concentration of Prednisolone phosphate can be increased when it is combined with Umeclidinium.
Butobarbital
Remdesivir
The serum concentration of Remdesivir can be increased when it is combined with Umeclidinium.
Butobarbital
Fostemsavir
The serum concentration of Fostemsavir can be increased when it is combined with Umeclidinium.
Butobarbital
Selumetinib
The serum concentration of Selumetinib can be increased when it is combined with Umeclidinium.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3